The Serum Institute of India (SII)

Vaccine prices revealed by UNICEF

World’s largest vaccine buyer UNICEF, for the first time, has revealed its vaccine price list with the intent to bring down the cost of the vaccines by starting a competition among drug manufacturers.

On its website, UNICEF has disclosed the amount it paid to various drug-makers to purchase 16 vaccines in a 10-year period. The recent step set to bring greater transparency has not been endorsed by western pharmaceutical companies, who in some cases charge more than Indian companies.

Pune's swine flu vaccine 'Fluvac' to hit market in April-May

Pune-based Indian medical firm The Serum Institute of India (SII) announced Monday that their swine flu vaccine 'Fluvac' would be available in the market by April-May 2010.

swine_flu_vaccine.jpg

SII started the Phases two and three of the clinical human trials of the nasal form of vaccine Monday on 330 participants at different locations around the country.

According to Dr Prasad Kulkarni, the director of clinical trials at the institute, SII got the green signal from the Drug Controller General of India (DCGI) on March 5 to carry out advanced safety tests on the swine flu vaccine.

Clinical trials
As per reports, 330 people in three groups--paediatric, adult and elderly (9-19 years, 20-48 years and 48 and above)--will be put under the trial.

Syndicate content